The mean age of patients who carried deleterious variant in BRCA1/BRCA2 was 39 years and 8 months compared to 47 years and 3 months among women who carried a deleterious variants in other breast cancer susceptibility genes. This evidence concerns the gene BRCA2 and breast cancer.